A Review on Controlled Release Matrix Pellets for Oral Drug Delivery: Formulation, Evaluation and Recent Advances

Oral drug delivery is relatively cheap, safe, patient compliant and easy to use, hence, it remains the most popular and the most common mode of drug delivery. (Mote et al., 2011)The conventional oral dose preparations, such as tablets and capsules, are designed to discharge drugs immediately and as such often result in rapid absorption with a sharp decline in plasma drug concentration. In drugs especially with short biological half-life or low therapeutic index, this will cause phases of sub-therapeutic concentrations or toxicity and offer a unique peak-valley curve. To avoid these limitations, controlled release drug delivery systems have been developed to provide steady and delayed medication release.(Et Al 143 et al., n.d.)

To maintain plasma drug concentration within therapeutic range, controlled release delivery systems of drugs are developed to deliver drugs at a predetermined rate over a long period of time. (Haritha, 2012; Sirisha et al., 2013)These systems reduce the negative effects, enhance the therapeutic effect, reduce the number of doses, and enhance the compliance of patients. Compared to all the various controlled release techniques, oral controlled release techniques have been investigated most because they are easy to administer, and patients have accepted them. Oral CR systems control the release of drugs using different mechanisms, which include, but are not limited to, diffusion, dissolution, erosion, swelling, and osmosis.(R. Khan et al., 2014)

1.1 Systems Oral Controlled Drug Administration

Oral controlled drug delivery systems attempt to optimize the pharmacodynamics and pharmacokinetic characteristics of drugs by controlling the rate, duration, and even the site of drug discharge into the gastrointestinal tract. (Wairkar & Gaud Shobhaben Pratapbhai, 2016)The systems come in particularly handy in long-term management of chronic illnesses such as diabetes, peptic ulcer disease, hypertension and neurological issues. Oral CR systems reduce the variations that may lead to side effects or treatment failure by maintaining comparatively steady plasma levels of medication.(Abbaspour et al., 2025)

Oral controlled release formulations are divided into two broad groups, namely, matrix systems and reservoir systems. Whereas in the matrix system the drug is spread uniformly throughout a polymeric framework, in reservoir system the drug core is confined within a rate controlling membrane. Due to their superior safety and effectiveness design, multiparticulate systems such as pellets, granules and mini-tablets have become important compared to single-unit dose forms.(Mohaniya et al., 2024)

1.2 The Pellets Release Requirement Requirement regulated release pellets

Pellets are round or semi-round, small, free-flowing spheres usually packed into pills or even into capsules. The disadvantages of the traditional single unit dosage forms, which include dose dumping, uncertainty of emptying of the gastric tract and the risk of local G.I irritation compel the use of controlled release pellets.(Divyasree, n.d.) After delivery, the controlled release pellets are spread evenly across the gastrointestinal tract and enhances the consistency of medication absorption and reduces inter- and intra-subject variability.(A. Khan et al., 2014)

Since the entire amount of drug is divided into many discrete units, the other important advantage of controlled release pellets is that they reduce the risk of dose dumping. This property is especially essential to drugs that have a narrow therapeutic index. Pellets also offer the flexibility in formulation as well since it is possible to combine different populations of pellets having diverse release properties to produce the desired therapeutic effects. Also, medication that irritates the gastrointestinal tract or has a sustained plasma level or unstable in gastrointestinal conditions should use controlled release pellets.(Rajendra Bafna et al., n.d.-a)

The advantages of using Matrix Pellets over Standard Dosage Forms

Matrix pellets are a complex form of controlled discharge multiparticulate technology, where the drug is incorporated in a polymeric structure. Such systems have several strengths compared to controlled release systems of single unit and conventional dose forms. (Rajendra Bafna et al., n.d.-b)The pellets of matrices offer higher bioavailability, reduced local irritation, enhanced control of the drug, and enhanced compliance of the patient. (Pai et al., 2012)

Pellets of matrices have uniform distribution of drugs along the gastrointestinal tract, deferent emptying of the stomach, and they are less dependent on meal effects compared to conventional tablets.(Gaware et al., n.d.) The polymer matrix controls the release by inhibiting the diffusion of drugs and controlling their release by erosion, swelling, and diffusion. Besides, the matrix pellets are easier to manufacture than the coated reservoir ones, and are not as much vulnerable to defects like the coating rupture.(Achenie & Pavurala, 2017)

Finally, the controlled release matrix pellets consist of the benefits of multiparticulate systems and controlled drug delivery. Being versatile, safe, and effective, they are an attractive dosage form in modern pharmaceutical development and a field of intense research in oral controlled drug delivery.(Hariom et al., 2014)

Pellets as Drug Delivery Systems with Multiple Parts

Pellets are the most popular multiparticulate drug delivery devices that consist of small, discrete pieces that are used to deliver a single therapeutic dose. Unlike traditional single-unit dose such as tablets, pellets spread uniformly across the gastrointestinal tract after they are delivered. Due to this feature they are particularly appropriate in application in areas where there is controlled and extended medication administration. The pellets are often made into a small ball-like form into a tablet that contains pellets or in hard gelatin capsules. (Al-Hashimi et al., 2018)They are usually spherical or semi-spherical in shape and they are not bigger than 0.5 to 2.0 mm.

2.1 Definition and Qualities 

The pelletization process is the enlargement process where fine powders of medicine and excipients are converted into small-sized spherical and freely flowing particles referred to as pellets.Pellets are free-flowing, they are characterized by a narrow distribution of the sizes, low friability, and high mechanical strength. The content homogeneity of the pellets, required in the dosing of the strong medications, is due to its uniform shape and size.(Yadav & Verma, 2016)

The capacity of pellets to evenly spread along the gastrointestinal tract is a critical characteristic of multiparticulates. This results in reduced dependence on physiological aspects such as food consumption and stomach motility and predictable emptying of the stomach.(Garg et al., 2008) Also, pellets decrease the incidence of gastrointestinal discomfort since localized concentration of the medication at a local site is reduced. Depending on the formulation design, the pellets may be made into instant release, sustained release, delayed release or site-specific delivery system.(Malleswari et al., n.d.)

2.2 Advantages and limitations of Pellets

Multiparticulate pellet systems have several benefits compared to single-unit dose forms. Due to the fact that the entire dose of the drugs gets split into multiple subunits, the reduced likelihood of the drugs dumping is seen as one of the largest advantages. The overall release profile is not significantly influenced by some of the pellets that fail or rupture, hence, patient safety is enhanced. This is quite beneficial in the case of medications that possess a narrow therapeutic index.(Mondal, 2018)

Homogenous distribution of pellets across the gastro intestinal tract minimizes inter and intra subject variability in the absorption of drugs. They demonstrate more frequent emptying of stomach and reduced food effects compared to tablets. Formulation versatility is also achieved with pellets as the ability to blend pellets with different release profiles allows the achievement of the desired therapeutic effects to be found. They can thus be used in delivery of chronotherapeutic medication and combination therapy.(Suchita, 2022)

In summary, the multiparticulate drug delivery systems in the form of pellets are safer, more therapeutically effective, and allow more control over the release of drugs. 

Controlled Release Matrix Systems

Controlled release matrix systems are one of the most popular and well studied systems of administering oral controlled medications. In such systems, the drug is incorporated or uniformly mixed in a polymeric framework that regulates the drug discharge over a prolonged duration of time. Matrix systems are preferred over reservoir-based systems in the pharmaceutical development due to ease of operation, attractiveness, reproducibility, and less risk of dose dumping. They are particularly effective when they are developed in the form of multiparticulate, i.e. pellet systems.(Varma et al., 2004a)

Controlled release matrix pellets are a combination of the benefits of multiparticulate drug delivery and matrix systems. The polymer matrix serves as a barrier that controls the rate of diffusion, erosion, swelling or a combination of the aforementioned mechanisms by altering the drug release rate. The release profile is customizable by selecting appropriate polymers and changing the formulation and manufacturing parameters.

3.1 Release Concept The Matrix Drug Release Concept

The fundamental concept of matrix drug release is to incorporate the active medicinal ingredient into a polymeric network. The surrounding medium penetrates the surface of the pellet, and reacts with the polymer when matrix pellets are exposed to gastrointestinal fluids. In the case of hydration, it brings about swelling, gel or gradual falling apart of the matrices, depending on the type of polymer.(J. M. Ghormade et al., 2023; Varma et al., 2004b)

Hydrophilic matrix systems cause the formation of a viscous gel layer around the surface of the pellet because of the relaxation of polymer chains that has been penetrated by water. The gel layer retards the movement of drug molecules out of the matrix to the dissolving media by providing a diffusion barrier. Sustained release can be observed due to the fact that the outer gel layer will wear away with time and new layers of gel will grow inner.

Hydrophobic matrix systems limit water penetration and diffusion of drugs is the primary route of drug release through channels and pores formed in the matrix. The rate of releasing the drug depends on drug solubility, porosity, and permeability of the matrix of the polymer in these systems. The fact that matrix methods do not require the extra coating step and that they allow homogenous distribution of the drug makes them extremely production-friendly.(Shekhar et al., 2023)

3.2 Matrix Pellet Drug Release Mechanism

Controlled release matrix pellets often end up releasing drugs through one or more of the following overlapping pathways: 

Diffusion Control Release: 

Diffusion-controlled devices release the medication out of the matrix into the surrounding medium through swelling polymer networks or water-filled pores of networks.(Krogel & Bodmeier¨college, 1999a) This mechanism is common in hydrophilic polymers in the form of pellets, such as those that contain hydroxypropyl methylcellulose (HPMC). The rate of release is influenced by the drug solubility, the polymer viscosity and the thickness of diffusion barrier.

Erosion-controlled release: The erosion-controlled systems involve the release of the medicine in which the erosion or dissolution of a polymer matrix in the gastrointestinal environment causes the release of the medicine. It is usually common with soluble polymers or biodegradable polymers. the role of medication solubility on the release of drugs is not as influential as the rate of degradation of the polymer. Erosion-controlled release can be used to obtain near zero-order release profile.(Krogel & Bodmeier¨college, 1999b)

Swelling-controlled release: Swelling-controlled systems entail the use of hydrophilic polymers that absorb water and swell significantly on hydration. The swelling polymer forms a gel barrier that controls the drug diffusion. The equilibrium of the erosion, diffusion and swelling defines the overall release profile. Due to the ease with which swelling-controlled release can be modulated and reproducible, swelling-controlled release is commonly used in matrix pellets. 

Most controlled release matrix pellet formulations release their drugs by a mixture of erosion, swelling, and diffusion and not through one process. The combination mechanism makes the matrix pellets suitable in the long-term treatment due to this mechanism of producing more consistent and longer release of drugs.(Kardile et al., 2023; Tapaswi et al., 2013)

Polymers in the Matrix of Controlled Release Pellets

Polymers are the most significant components of controlled release matrix pellets because they determine the procedure and speed of drug discharge. The selection of polymer has significant effect on the physicochemical properties of the pellets including swelling behavior, matrix integrity, drug diffusion, and erosion rate. In the case of controlled release pellets, an ideal polymer would be non-toxic, stable, biocompatible, compatible to the medication and capable of providing consistent and repeated drug delivery. (Zuleger & Lippold, 2001)

The polymers employed in controlled release matrix pellets may be approximately classified as hydrophilic, hydrophobic or natural according to their interaction with aqueous media. (Alhmoud, n.d.)Each of the classes has different release properties and formulation benefits.

4.1 Polymers Hydrophilic 

Hydrophilic polymers are the most widely used materials in the controlled release matrix pellets because they are able to absorb water, swell and create a gel layer around the pellet surface when they contact gastrointestinal fluids. (Kavitha et al., n.d.; Penkov et al., 2023)This hydrated gel layer controls the diffusion of the drug out of the matrix, it acts as a rate-limiting barrier. The process of diffusion and erosion usually complement each other to free drugs on hydrophilic matrix.

Hydroxypropyl methylcellulose (HPMC) is the most common hydrophilic polymer that is used in controlled release pellets in formulations. Due to its numerous classes of viscosity, concentration and grade of the polymer can be accurately set to regulate the release of the medicines.(Boyapally et al., 2009; Sonawane & Patil, 2016) To make the required release profiles Hydroxypropyl cellulose (HPC) that can swell is often used either by its own or in combination with HPMC. Sodium alginate is a hydrophilic hydrogel, which is a naturally occurring hydrophilic polymer and is useful in gastro-retentive and sustained preparations due to its ability to form a thick gel when mixed with watery media are present.(Singh et al., 2021)

Hydrophilic polymers can be used with both water-soluble drugs and drugs with low solubility. The diffusion channel is lengthened and the gel is fortified by adding polymer increasing the polymer concentration which will delay the release of the medication by default. These polymers are preferred due to their predictable release properties, easy production and safety. (Manna & Kollabathula, 2019; Zhou et al., 1997)

 4.2 Hydrophobic Polymers

Hydrophobic polymers are water-insoluble substances, which control the discharge of medications by forming a non-swellable, matrix-like structure. Unlike the hydrophilic polymers, hydrophobic polymers do not form a gel layer; rather, diffusion through matrix structure pores, fissures or channels is predominantly the mode of drug release.(Tangde & D Ss saboo, 2021)

Ethyl cellulose is one of the most used hydrophobic polymers in formulations of controlled release pellets. It provides effective release retardation especially when the medication is highly soluble in water.(Bölcskei et al., 2012) Eudragit RS and RL ammonio methacrylate copolymer is also commonly used. The quantity of quaternary ammonium groups in these polymers can vary which means that the polymers are permeable, and one can easily control the output of drugs.

Hydrophobic polymers can be used in sustained release owing to its long term and pH insensitive drug release. They are often paired with hydrophilic polymers to circumvent constraints such as partial release of medication and to generate less irregular release profiles. (Schmidt & Bodmeier, 2001; Tsai et al., 1998)

4.3 Organic Polymers 

Natural polymers are increasingly gaining popularity in controlled release matrix pellets due to their environmental friendliness, biodegradability and biocompatibility. These polymers are natural polymers and are usually cheap and non- toxic.(Rao et al., 2003)

Starch is commonly used as a release-modifying agent and matrix forming. In presence of water it swells and controls the release of medication through erosion and swelling processes.(Chaudhari et al., 2017; Möschwitzer & Müller, 2013) Chitosan is a bioadhesive cationic polysaccharide, which is highly applicable in the targeted and controlled delivery of medications. Guar gum is a galactomannan polysaccharide that swells and hydrates in the aqueous environment to release drugs over a duration of time.(B et al., 2019)

Materials Used in Matrix Pellets

Mechanical strength, drug release behavior, and the overall stability of the dosage form are also influenced by excipients, which is critical in the formulation of controlled release matrix pellets. Besides the polymer and active medicinal ingredient, excipients are used to give the required processing properties that include homogeneity, compressibility and flowability. (Ahmad et al., 2014)The selection and optimization of excipients have significant influence on the performance, quality and repeatability of matrix pellets. (Shukla et al., 2020)

The most significant groups of excipients used in the matrix pellets are diluents (fillers), binders, lubricants, and glidants. In the process of pelletization, every type of category plays a role in controlled drug release and serves a specific purpose.(Kállai et al., 2010)

5.1 Diluents 

Diluents also known as fillers are introduced to matrix pellet compositions to increase bulk volume, processability, and provide structural integrity to pellets. As they provide the wet bulk with cohesion and flexibility, they also play a major role in extrusion-spheronization. 

Microcrystalline cellulose (MCC) is the most commonly used diluent in pellet formulation due to its effectiveness in binding, plastic deformation, and is greater in ability to hold water. The extrusion and spheronization are simplified by MCC to give uniformly sized spherical pellets of high mechanical strength. (Siepmann et al., 2006)It also contributes to controlled release of medication by developing a stiff matrix structure.

Other common diluents are dicalcium phosphate, lactose, and mannitol. Although mannitol provides a pleasant feel and is preferable when using drugs that are sensitive to moisture, lactose is used to increase the density of pellets and drug dispersion. (Nikolakakis & Partheniadis, 2017)The nature and concentration of diluent affects the pellet hardness, porosity as well as the rate of drug release. (Vo et al., 2016a)

5.2 Binders 

Binder is used to maintain integrity of the pellets after drying as well as providing the powder blend with cohesion during wet massing. The particles of the medication and excipient are retained together, which contributes to the creation of a stable pellet.(Vo et al., 2016b)

Common binders include polyvinylpyrrolidone (PVP) and hydroxypropyl methylcellulose (HPMC) and hydroxypropyl cellulose (HPC) and starch paste.(Wang et al., 2010) PVP is highly utilized due to its high binding capacity and aqueous and organic solubility. HPMC and HPC are binders as well as release-retarding agents in matrix pellets. 

Binder concentration has a strong influence on pellet strength, size and medication release. Poor binder may lead to friable pellets and inconsistent content but when it is overly high, it may lead to hard pellets and decreased drug release. (Pauli-Bruns et al., 2010)

5.3 Glidants and Lubricants

Lubricants and glidants are used to increase the flow properties, reduce friction during processing and elimination of pellet agglomeration. They are particularly essential to the filling of capsules and compression of pellets to tablets. (Aguilar-De-Leyva et al., 2011)

The most popular lubricant is magnesium stearate but excess may lead to formation of hydrophobic layer around powder thus slowing down drug release. Talc is applied as a lubricant and glidant in order to enhance flowability and reduce sticking. Colloidal silicon dioxide is common glidant that is used to enhance flow and reduce the friction among particles.

Lubricants and glidants should be well selected and optimized since excesses of them may alter the integrity of pellets and dissolution characteristics. (de Sousa Borges et al., 2026)

5.4 Additional Excipients

In order to increase the release and stability of the medication, additional excipients may be added to the matrix pellets this includes plasticizers, wetting agents and pH modifiers. Poorly soluble drugs dissolve easier with the addition of wetting agents such as sodium lauryl sulfate. Whereas the pH modifiers help to maintain an appropriate environment in which the drugs remain stable, plasticizers enhance plasticity and reduce brittle nature of polymer matrices.(Kumari & Kumar Sharma, 2021)

Procedures for Making Matrix Pellets

The production process plays an important role in the quality of controlled release matrix pellets and their functionality as well as drug release behavior. Pelletization processes aim at producing spherical units containing homogenous amounts of medication, high mechanical strength, and narrow size distribution. The nature of the drug, polymer, targeted release profile, and scalability are all factors that influence the selection of the most suitable method of preparation. The most commonly used methods of creating matrix pellets are extrusion spheronization, solution/suspension layering and stacking of powder.(Vergote et al., 2001)

6.1 Extrusion-Spheronization 

Extrusion-spheronization is the most popular and preferred method of producing matrix pellets due to its ability to produce pellets that are of uniform size, excellent sphericity and large drug loading. (Blanqu6 et al., 1995)This method is especially suitable with formulations that contain hydrophilic or hydrophobic polymers that are intended to release gradually.

The process involves dry mixing, wet massing, extrusion, spheronization and drying. Dry mixing entails a regular mixture of the drug, polymer, and the excipients.(De Brabander et al., 2003) Wet massing is used to form a plastic mass into which a suitable granulating liquid is added. Cylindrical extrudates are manufactured by pressing the wet material through a die or a screen. These extrudates are then broken and molded into spherical pellets in the process of spheronization by centrifugal and frictional forces. (Nasiri et al., 2016)

Finally, the pellets are dried to get rid of any left-over moisture. 

Some of the advantages of extrusion-spheronization are reproducibility, large drug loading capacity and ease of scaling up. In order to ensure the quality of every pellet remains the same, though, some machinery and fine-tuning of the parameters in the processes, including moisture level, extrusion rate and spheronization duration, are required.

6.2 Solution and Suspension Layering Solution and Suspension

In situations where the drug is prone to dampness or mechanical forces, the matrix pellets are often made through solution or suspension stack. In this method, after dissolving or suspending the medicine, it is coated onto non-toxic sacs as starting cores such as sugar strains or microcrystalline cellulose beads. (Mansoori, 2017; Sarita et al., n.d.)

The process of layering is normally conducted with the help of coating pan or fluidized bed processor. A spray of medication solution or suspension is applied to the cores in order to conduct solvent evaporation by spraying heated air over them. The process is repeated until the necessary particle size and the drug loading is achieved. Polymers may be incorporated as an additional layer of the matrix or into the drug layer in order to control drug release following drug layering.(Issa et al., 2017)

In case of low-dose drugs, solution/suspension layering provides an excellent control of particle size and uniformity. However, it is time consuming, consumes a lot of solvent, and may not be suitable with drugs that are insoluble and those that are unstable in solution. 

6.3 Layering of Powder

Powder layering is the procedure of applying a binder solution to cores of starting core with the purpose of adding powdered medication. The binder is an adhesive which enables the drug particles to adhere to the core surface. This method is commonly performed in fluidized bed processor. (Aher et al., n.d.-a)

Dry powder and binder solution are used in the procedure of powder layering in alternating sequence until the desired size of particles is achieved. It is possible to add matrix-forming polymers to the powder layer or apply an extra layer of polymeric matrix so as to give controlled release properties.

Since exposure to heat and solvents is minimized in powder stacking, it is particularly convenient in drugs that are both thermolabile and hygroscopic. High sticking and uniform distribution of medication, in turn, might be challenging to obtain and require precise control of the process settings. (Aher et al., n.d.-b)

6.4 Selection and Comparison of the Methods

All pelletization methods have some advantages and disadvantages. Extrusion-spheronization is preferable to layering when large drug loading and robust pellets of the matrix are required although smaller size and surface characteristics can be better controlled using layering.(Cosijns et al., 2009) The specifications of the formulation, accessibility of equipment and the release kinetics to be used as well shapes the method choice.(Gupta et al., 2015)

Assessment of the Controlled Release Matrix Pellets

In order to ensure product quality, performance and reproducibility, controlled release matrix pellets need to be tested. Extensive evaluation determines whether or not the pellets exhibit the desired or controlled release profile or not and whether or not the pellets meet pharmacopeial criteria. Both the biological and the physical features are considered, because the attributes of a pellet have a direct effect on the safety of the patient, on the stability of the pellet and in the release of the drug.(Zhong, 2020)

7.1 Pellet size and shape Analysis

Pellet size and shape are important aspects on quality that can influence flow characteristics, capsule filling, content homogeneity, and medication release behavior. Regular dosage and reproducible release is ensured by even particle size. Sieve analysis is often used to determine particle size distribution. Pellets are filtered using a number of standard sieves and the percentage that is retained on each sieve is calculated.  Optical microscopy is used to determine the shape of the pellets, surface properties, and sphericity.  Scanning electron microscopy (SEM) can be used to examine surface morphology and porosity as well as the distribution of polymer.

7.2 Properties of Flow 

Good flow characteristics are required when its production is on a large scale and when it comes to efficient capsule filling. Pellet flow behavior is measured using the following criteria: Angle of repose: Demonstrates the behavior of pellet flow; the lower it is, the superior is the flow behavior. Bulk density and tapped density are used to evaluate the packing qualities.  Hausner ratio and index of Carr: Display characteristics of flow and compressibility. 

Their spherical shape renders pellets to possess better flow properties than the powders and granules.

7.3Friability and Mechanical Strength

Mechanical strength is required in order to preserve the integrity of the pellets through handling, coating, filling capsules, and its transportation. In order to measure the resistance to abrasion, friability is performed using a friabilator.  Low friability levels are a sign of good mechanical strength and durability. 

The profile of drug release can be altered when low strength pellets of low mechanical strength break.

7.4 Content Uniformity and Drug Content

Drug content guarantees that accurate dosage and the consistent distribution of drugs among pellets occur. A particular volume of the pellets is crushed and dissolved in a suitable solvent.  The amount of drug can be established by HPLC or UV spectroscopy. The results should reach pharmacopeial limits. 

In the case of low-dose formulations especially, even medication distribution is very important.

7.5 Content of Moisture

The moisture content affects the drug release behavior, hardness and the pellet stability. This was determined by Karl Fischer titration/loss on drying (LOD). • Excessive moisture might cause medicine deterioration, growth of microbes or agglomeration of pellets. 

7.6Optimum moisture levels ensure stability and stable operation

Dissolution The dissolution of the solid was studied by in-vitro methods using a 4.0 M HCl solution.Dissolution: - The dissolution of the solid was investigated by in-vitro techniques through 4.0 M HCl solution.

As it determines the behavior of drug release, the most important assessment criterion of the controlled release matrix pellets is the in-vitro dissolving testing. USP dissolving with used either equipment II (paddle) or apparatus I (basket). The selection of the conditions and media used in dissolution is done in consideration of the target release profile and drug properties. Samples are also removed and analysed at specified times. 

During the intended period of time, the dissolution profile must demonstrate continuous and stable drug release. 

7.7 Kinetic Models of Release 

Dissolution data are fitted to different kinetic models to understand the mechanism of drug release:

 Zero-order kinetics is indicative of constant drug release.  First-order kinetics: Release is dependent on drug concentration. Diffusion-controlled release is explained by Higuchi model. Korsmeyer-Peppas model: Korsmeyer usefulness model is a model, which applies the release exponent (n value) to find out the release method. 

Two advantages of the kinetic analysis are understanding the behavior of release and the enhancement of formulation parameters. 

Erosion and Swelling studies: Erosion happens when the earth mass receives a continuous influx of magma, while swelling occurs when the mass subcontracts

7.8 Studies on Erosion and Swelling 

Erosion occurs when the earth mass is constantly supplied with magma and swelling occurs when the mass contracts. 

The swelling and erosion behavior of matrix pellets can be used to deduce drug release mechanisms. The swelling index is computed by increasing the weight of pellets when they are in the dissolving liquid. Erosion studies determine the weight loss with time. 

These researches are particularly important to hydrophilic matrix pellets.

7.9 Research on Stability 

Stability experiments are conducted to determine the influence of temperature and humidity on the quality of the pellets and medication release in compliance with the ICH regulations.The physical properties, pharmacological content, and dissolving of the pellets are analyzed. 

Uninterrupted performance is ensured during the shelf life of stable formulations. 

The fifth approach involves in-vitro -in vitro correlation (IVIVC).

According to the IVIVC research, in-vitro dissolution and in vivo medication absorption are interrelated. 

reduces the need to conduct extensive research on bioavailability.

Factors Influencing the Controlled Release Matrix's Drug Release Pellets

The release of drugs is regulated by many parameters of formulation and the process, which act on controlled release matrix pellets. It is necessary to understand these aspects in the design of pellets that can be released in predictable patterns, repeatable patterns, and desired patterns. A change in the properties of the polymer, pellet size, properties of the drug, or manufacturing conditions may significantly affect drug release kinetics and therapeutic efficacy.

The polymers are of the type and concentration specified below.

8.1 Type and Concentration of Polymers 

The type and concentration of polymer used in the form of matrix pellets is predominantly used to control drug release, hydrophilic polymers (sodium alginate, HPMC, and HPC) swell to form a gel and thereby control drug transport when they are hydrated.Hydrophobic polymers, including ethyl cellulose and Eudragit RS/RL, inhibit water diffusion to control the rate of drug release, and create a gel layer that regulates drug transport. 

The property of the release can be optimized by selecting the appropriate polymer mixtures.

8.2 Surface Area and Pellet Size

 Since pellet size influences the surface area, it also impacts directly on drug release behavior.  The use of smaller pellets leads to release of drugs faster due to high surface area-volume ratio. Drugs are less quickly released into the blood because they are bigger in size. Reproducibility and uniform drug release is guaranteed by narrow size distribution. 

A controlled release performance depends on uniform pellet size therefore. 

8.3 Drug Solubility and Dose 

Physicochemical characteristics of drugs have a great impact on release kinetics.  Very soluble drugs in water tend to diffused easily, thus becoming very hard to be controlled in terms of release.  Poorly soluble drugs have long release because of their low solubility.

The result of high drug loading in the matrix might be faster release due to high porosity. 

In order to control the dissolution of highly soluble drugs, the process of solubility augmentation such as polymer blends is common. 

8.4 Pellet and Matrix Pellet Density and Matthews porosity

High porosity contributes to faster penetration of the dissolving media of drugs by the matrix and increases permeability by the fluid. 

The dense matrices reduce drug diffusion by the inhibition of fluid accessibility.Pellet density is influenced by compression forces, by the condition of spheronization, and by the type of diluent. 

Constant and controlled release of medication is ensured by optimized porosity.

8.5 Excipient Type and Quantity 

Excipients like lubricants, binders, and diluents have an effect on drug release behavior. 

Excipients that are hydrophilic accelerate the release of medication and enhance water absorption. 

Hydrophobic excipients retard the release of the drug. 

Presence of excessive amount of lubricants may result in a hydrophobic coating of the drug, thereby reducing drug release. 

The desired release kinetics necessitate a close choice of excipients. 

8.6 Parameters for Processing 

The manufacturing conditions remarkably affect the quality of the product (pellet) and the quality of medication release (moisture content during wet massing).The size and form of the pellets are influenced by the spheronization time and the speed of the extrusion (drying conditions). 

The possibility of batch-to-batch variability is associated with poor control over processing parameters.

8.7 PH Dissolution Media in the Environment 

The pH of the dissolution media affects the drug solubility and polymer swelling. 

Various GI regions can have different discharges of pH-sensitive polymers.GI tract is invariably discharged by pH-independent ones. 

Dissolution tests under different pH levels are useful in predicting the in-vivo behavior. 

8.8 Behavior of Erosion and Swelling

The release processes of the drugs are dependent on the swelling and erosion of the polymer matrix, which causes diffusion to stop and thickens the gel, and the opposite is true.To obtain a long-term release, the swelling and erosion have to be equalized. 

These properties are greatly influenced by the type and the concentration of the polymer.

Current Developments in Controlled Release Matrix Pellets

Studies related to controlled release pellets in the form of matrix are evolving. In the last decade, scientists have focused on enhancing manufacturability, strength, functionality expansion (floating, mucoadhesion, targeting), better release control and the introduction of modern quality-by-design and continuous manufacturing. The important recent developments are summarized as below. 

9.1 Improved Process Engineering/Pelletization

 Enhancement of extrusion-spheronization: Better control of wet mass rheology, improved sphericity, density, and lot-to-lot repeatability of pellet materials has been achieved through improved binder systems, better control of extrusion speed, and comprehensive investigation of key process parameters (moisture, extrusion speed, and spheronization time). These improvements make predictable control releases behavior.

Switch to processes which are continuous and require solvents to be minimized: To increase throughput and reduce solvents processing/solvent handling times of layering processes, the continuous extrusion/spheronization variants and solvent-minimized layering systems are in development. This improves the scale-up and regulatory compliance.

9.2 Multipurpose Pellets: There are various kinds of pellets

Floating (gastro-retentive) pellets: Floating of drugs with a stomach/ upper-GI absorption window To enhance absorption and increase the gastric residence time, new designs ( hollow, low-density cores, gas-forming excipients) and hybrid floating- bioadhesive designs are employed. These designs are being perfected in order to have controlled release and repeatable buoyancy. 

Bioadhesive pellets: The use of mucoadhesive polymers (chitosan, carbomers and thiolated polymers) to maintain the attachment of the site; useful in the target GI site absorption and local therapy. 

Self-emulsifying/solubility-enhancing pellets: Adding solid dispersions or self-emulsifying preparations to the pellets will enhance the release of poorly soluble drugs and retain the controlled release. This is a multiparticulate controlled release and improvement in solubility.

9.3 MUPS or combination therapy or Pellets-in-Tablet

Multi-unit pellet system (MUPS): Pellets-in-capsules and multi-unit pellet system (MUPS): Compressed coated or sustained release pellets are simultaneous into tablets (or combined with pellets with different release patterns) in fixed dosage combination therapy and chronotherapeutic release patterns. The advancement in pellet coatings and cushioning excipients has reduced deformations and release profiles remain constant during compaction. 

9.4.Innovative Polymers and Polymer Blends

Matrix of hybrid polymers Matrix-based Swelling, erosion, and diffusion Swelling, erosion, and diffusion can all be tailored to achieve customized release kinetics by mixing hydrophilic (such as HPMC, HPC) polymers with hydrophobic (such as ethyl cellulose, Eudragit RS/RL) polymers and incorporating additional more recent functional polymers (such polyethylene oxides, modified natural gum). Recent studies indicate that ratios and grades can be programmed to conform to the desired traits.

Biomaterials such as chitosan, derivatives of guar gum and modified starches are increasingly gaining popularity as biopolymers and functional natural excipients in biodegradable patient-friendly matrices. These materials are commonly modified in terms of chemicals or physically to enhance mechanical strength and reduce batch variation. 

9.5 Systems of Developing Low-solubility Drugs

To achieve enhanced dissolution as well as prolonged delivery (important to many BCS II drugs), solid dispersions and lipid/self-emulsifying systems are pelletized (layering or co-matrixing). From a research done, optimized stability and in vitro release is favorable. 

9.6 Targeted and Site-Specific Distribution 

Colon-targeted pellets: Colon-targeted pellets based on natural polysaccharide coatings (like pectin and guar) using microbiotabasically triggered erosion and multiple coat methods (enteric + enzyme/pH sensitive subcoats) provide better colon localization to local disorders. The accuracy of the releases has been enhanced by multi-layer techniques and encapsulations.

 9.7 Patient-Centric and Pediatric Designs.

Dose flexibility and mini-pellets Extrusion-spheronization and layering methods have been adapted to form little, standardized particles; mini-pellet and taste-masked multiparticulates research are helpful in pediatric and geriatric dose flexibility. These products are easy to sprinkle on food or mix them in drinks. 

9.8.The Analysis and Regulation advances are 

Quality by Design (QbD) and PAT: Greater adoption of QbD paradigms and process analytical technologies (near-IR, FBRM, Raman) would allow greater real-time control over such crucial attributes as moisture, particle size, or sphericity to enhance IVIVC opportunities and reduce batch variability. These tools are increasingly used in the development and scale-up. 

Improved IVIVC approaches: In numerous pellet systems, predictions of in-vivo behavior using in-vitro data have been enhanced by improvement of dissolving testing, biorelevant media, and modeling, however, IVIVC remains formulation-dependent.

Controlled Release Matrix Applications Pellets

Due to their multiparticulate character, versatility in conception as well as ability to produce extended and predictable drug release, controlled release matrix pellets are broadly utilized in pharmaceutical drug delivery. These systems find extensive application in systemic and local drug administration as a variety of therapeutic applications. 

10.1 Long-term and Continuous Drug Administration:- 

One of the most notable applications of controlled release matrix pellets is sustained drug delivery whereby the drug is discharged through a prolonged duration of time to ensure steady plasma drug levels. This application is particularly beneficial to drugs whose biological half-life is short as it reduces dose frequency and enhances patient compliance. Sustained release pellets reduce the changes in the level of medications by reducing the side effects and enhancing the treatment effectiveness.

10.2 Gastro-Retentive Medication Administration:-

Controlled release matrix pellets are often used in the gastro-retentive drug delivery system, i.e., floating or bioadhesive pellets. These formulae prolong the gastric retention period by enhancing the absorption of drugs that are generally absorbed in the stomach or the upper part of the small intestines. Gastro-retentive pellets may be used in the use of proton pump inhibitors, the treatment of Helicobacter pylori, and unstable medicines in gut pH.

10.3 Site-Specific and Delayed Drug Delivery: -

Matrix pellets can be used as delayed or site-specific delivery of medication, e.g. intestine or colon-targeted delivery. The release of drugs can be controlled to specific regions within the gastrointestinal tract using pH-sensitive or enzyme-degradable polymers. This application is especially useful in the treatment of local diseases like the irritable bowel syndrome, colon cancer, and inflammatory bowel disease.

A narrow therapeutic index implies that a single drug is ineffective in managing diverse psychiatric disorders.

10.4 Drugs with Limited Therapeutic Index: -

Controlled release matrix pellets are particularly suitable with drugs having a narrow therapeutic index where it is important to maintain the plasma drug concentration within a safe dose level. The multiparticulate format of pellets reduces the risk of dose dumping and enhances patient safety because controlled and slow medication delivery is possible. 

10.5 Reduced Negative Responses to the Digestive System:- 

Pellet-based methods of delivering the drug to the gastrointestinal tract can reduce gastrointestinal discomfort as well as localized drug concentration of the gastrointestinal tract by distributing uniformly. This use is beneficial with drugs that are known to irritate the stomach when consumed in the form of regular pills.

CONCLUSION

Controlled release matrix pellets are one of the brightest and most versatile ways of delivering drugs orally in modern pharmaceutics. Combined with any controlled release technology, their multiparticulate structure offers several benefits over other traditional forms of single-unit dose such as tablets and capsules. The use of matrix pellets fosters uniform and repeatable drug absorption, ensures even distribution of the drug along the gastrointestinal tract and reduces the possibility of dose dumping by dividing the entire drug dose into multiple separate units.

The selection of polymers, excipients, and the ways of preparation must be carefully chosen as the key to the successful design of controlled release matrix pellets. Drugs release can be controlled by means of erosion, swelling, and diffusion by using natural, hydrophilic, and hydrophobic polymers. The versatility in the choice of the polymer gives the formulation scientists the ability to tailor medication release profiles to therapeutic requirements. The advances in excipient functionality and processing technology have greatly enhanced the quality of pellets, mechanical strength, and the release repeatability.

A wide range of pelletization procedures can be used to manufacture high-quality matrix pellets with a fine size distribution and excellent flow properties, the layering and extrusion-spheronization processes being the most notable ones. Stringent assessment standards, including mechanical, dissolution and physical qualities ensure compliance with regulation and uniformity of products. Also, strong formulations that are characterized by low batch-to-lot variance are realized due to an understanding of the process that affects drug release.

Recent advances, such as gastro-retentive systems, bioadhesive pellets, solubility-enhanced matrices, and pellets- in-tablet formulations have enormously expanded the number of therapeutic uses of controlled release matrix pellets. These advancements have solved poor solubility of drugs, site-specific delivery and patient-centric dosage designing. The application of quality-by-design (QbD) concepts, when combined with the process analytical technologies (PAT), has also improved formulation development, scale-up, and production efficiency.

In conclusion, controlled release matrix pellets are a reliable and diverse drug delivery system that has wide industrial and clinical applications. New manufacturing methods, formulation strategies and polymer science are expected to improve their performance and become more important in specific and personalized medication delivery through the continued research. Consequently, studies on controlled release matrix pellets by pharmaceutical sciences will remain valuable and vibrant.

ACKNOWLEDGEMENT

The authors are pleased to note that they enjoyed the unending support, good advice and encouragement of their guide during the writing of this review article. The authors also appreciate the faculty members of School of Pharmaceutical Sciences, JSPM University, Pune, who have helped in offering the requisite academic environment and resources. The works of researchers and scientists whose works have been referred in the current review are also thankfully noted as their findings have contributed greatly to the current study

REFERENCES

1. Abbaspour, M., Sadooghi, A., Khodaverdi, E., Sardou, H. S., & Nokhodchi, A. (2025). Preparation and evaluation of lipid-based sustained release pellets of chlorpheniramine maleate by the wet extrusion-spheronization method. BioImpacts, 15. https://doi.org/10.34172/bi.30098
2. Achenie, L. E., & Pavurala, N. (2017). Nov Appro Drug Des Dev Modelling of Drug Release from a Polymer Matrix System. 2. https://doi.org/10.19080/NAPDD.2017.02.555589
3. Aguilar-De-Leyva, Á., Sharkawi, T., Bataille, B., Baylac, G., & Caraballo, I. (2011). Release behaviour of clozapine matrix pellets based on percolation theory. International Journal of Pharmaceutics, 404(1–2), 133–141. https://doi.org/10.1016/j.ijpharm.2010.11.024
4. Aher, U. D., Shelke, T. T., & Patel, E. P. (n.d.-a). Recently used technologies in Pellet Formulation-A Review. 5.
5. Aher, U. D., Shelke, T. T., & Patel, E. P. (n.d.-b). Recently used technologies in Pellet Formulation-A Review. 5.
6. Ahmad, H., Khalifeh, I., Alkhalidi, B., Aiedeh, K., & AlKhatib, H. S. (2014). Application of active layering and coating techniques in the development of a multiparticulate, controlled release dosage form of a high-dose, highly soluble drug. Pharmaceutical Development and Technology, 19(5), 556–564. https://doi.org/10.3109/10837450.2013.805778
7. Al-Hashimi, N., Begg, N., Alany, R. G., Hassanin, H., & Elshaer, A. (2018). Oral modified release multiple-unit particulate systems: Compressed pellets, microparticles and nanoparticles. In Pharmaceutics (Vol. 10, Number 4). MDPI AG. https://doi.org/10.3390/pharmaceutics10040176
8. Alhmoud, H. A. (n.d.). The Uses of Matrices in Drug Delivery: The Effect of Polymers On the Drug Release and the Kinetic Models. Available Online Www.Ijpras.Com International Journal of Pharmaceutical Research & Allied Sciences, 2017, 13–20. Retrieved www.ijpras.com
9. B, G., S, N., NAGAM, S. P., & NADENDLA, R. R. (2019). FORMULATION AND EVALUATION OF EXTENDED RELEASE PELLETS OF PIOGLITAZONE HYDROCHLORIDE USING NATURAL AND SYNTHETIC POLYMERS BY FLUIDIZED BED COATING TECHNIQUE. Asian Journal of Pharmaceutical and Clinical Research, 438–446. https://doi.org/10.22159/ajpcr.2019.v12i3.30849
10. Blanqu6, D., Sternagel, H., Podczeck, F., & Newton, J. M. (1995). international journal of pharmaceutics Some factors influencing the formation and in vitro drug release from matrix pellets prepared by extrusion/spheronization. In International Journal of Pharmaceutics (Vol. 119).
11. Bölcskei, E., Regdon, G., Sovány, T., Kleinebudde, P., & Pintye-Hódi, K. (2012). Optimization of preparation of matrix pellets containing Eudragit ® NE 30D. Chemical Engineering Research and Design, 90(5), 651–657. https://doi.org/10.1016/j.cherd.2011.09.005
12. Boyapally, H., Nukala, R. K., & Douroumis, D. (2009). Development and release mechanism of diltiazem HCl prolonged release matrix tablets. Drug Delivery, 16(2), 67–74. https://doi.org/10.1080/10717540802586220
13. Chaudhari, P., Sonawane, R., & Deore, P. (2017). The Pharma Innovation Journal 2017; 6(2): 03-10 Pelletization techniques: Novel approach for drug delivery. www.thepharmajournal.com
14. Cosijns, A., Nizet, D., Nikolakakis, I., Vervaet, C., De Beer, T., Siepmann, F., Siepmann, J., Evrard, B., & Remon, J. P. (2009). Porous pellets as drug delivery system Porous pellets as drug delivery system. Drug Development and Industrial Pharmacy, 35(6), 655–662. https://doi.org/10.1080/03639040802578103
15. De Brabander, C., Vervaet, C., & Remon, J. P. (2003). Development and evaluation of sustained release mini-matrices prepared via hot melt extrusion. Journal of Controlled Release, 89(2), 235–247. https://doi.org/10.1016/S0168-3659(03)00075-0
16. de Sousa Borges, O., Kramer, J. O., Pascoa, H., de Paula Santos, Y. M., Freitas, L. S. O., Lima, E. M., Silva, L. A. D., & Diniz, D. G. A. (2026). From Liquid to Solid: Formulation and Characterization of Testosterone-Loaded S-SMEDDS Pellets Using a 24 Factorial Design. AAPS PharmSciTech, 27(3), 163. https://doi.org/10.1208/s12249-026-03329-2
17. Divyasree, V. (n.d.). A Brief Review on Multi Unit Pellet System. International Journal of Pharmaceutical Research and Applications, 9, 123. https://doi.org/10.35629/7781-0902123129
18. Et Al 143, P. H., Patel, H., Panchal, D. R., Patel, U., Brahmbhatt, T., Suthar, M., & Patel, M. H. (n.d.). 51) Matrix Type Drug Delivery System: A Review INTRODUCTION. In JPSBR (Vol. 1).
19. Garg, R., Gupta, G. D., & Gupta, G. &. (2008). Progress in Controlled Gastroretentive Delivery Systems. Tropical Journal of Pharmaceutical Research, 7(3), 1055. http://www.tjpr.org
20. Gaware, S., Kapdnis, N., & Kakulte, P. (n.d.). Review on:-"Multiparticulate System"AEmerging Trend In Drug Delivery System. International Journal of Pharmaceutical Research and Applications, 9, 678. https://doi.org/10.35629/7781-0901678684
21. Gupta, A. M., Shivhare, U. D., & Suruse, P. B. (2015). Different Aspects of Pellets Formulation and their Evaluation. In Int. J. Pharm. Phytopharmacol. Res (Vol. 4, Number 6). www.eijppr.com
22. Hariom, A., Rao, P., Iswariya, V. T., Lokeswara Babu, V., & Rao, A. S. (2014). A REVIEW ON CONTROLLED DRUG DELIVERY SYSTEM. Int J Pharm, 4(3), 275–282. http://www.pharmascholars.com
23. Haritha, V. N. (2012). MULTIPARTICULATE DRUG DELIVERY SYSTEM: PELLETIZATION. Pelletization. American Journal of PharmTech Research, 2(1). http://www.ajptr.com/www.ajptr.com
24. Issa, M. G., de Souza, N. V., Duque, M. D., & Ferraz, H. G. (2017). Physical characterization of multiparticulate systems. Brazilian Journal of Pharmaceutical Sciences, 53(4). https://doi.org/10.1590/s2175-97902017000400216
25. J. M. Ghormade, S. K. Yadav, P. V. Burakle, & A. S. Raut. (2023). The role of matrix tablet in controlled release drug delivery system. GSC Biological and Pharmaceutical Sciences, 23(1), 220–225. https://doi.org/10.30574/gscbps.2023.23.1.0157
26. Kállai, N., Luhn, O., Dredán, J., Kovács, K., Lengyel, M., & Antal, I. (2010). Evaluation of drug release from coated pellets based on isomalt, sugar, and microcrystalline cellulose inert cores. AAPS PharmSciTech, 11(1), 383–391. https://doi.org/10.1208/s12249-010-9396-x
27. Kardile, D. P., Awate, P. B., Bhagat, V. C., Birajdar, R. S., Shete, R. V, Lathi, S. S., Mathdevru, B. R., Pawar, O. P., & Mhetre, R. M. (2023). A Comprehensive Review of Recent Studies on Matrix Tablets for Drug Delivery with Oral Controlled Release. Biological Forum-An International Journal, 15(4), 789.
28. Kavitha, M., Vallakeerthi, N., Ramesh, P., & Reddy, P. M. (n.d.). A Review on Application of Different Polymers in Controlled Release Matrix Formulations.
29. Khan, A., Malviya, R., & Sharma, P. K. (2014). Multi Unit Drug Delivery System-A Brief Review of Pelletization Technique. World Applied Sciences Journal, 31(12). https://doi.org/10.5829/idosi.wasj.2014.31.12.8498
30. Khan, R., Ashraf, M. S., Afzal, M., Kazmi, I., Jahangir, M., Singh, R., Chandra, R., & Anwar, F. (2014). Formulation and evaluation of sustained release matrix tablet of rabeprazole using wet granulation technique. Journal of Pharmacy and Bioallied Sciences, 6(3), 180–184. https://doi.org/10.4103/0975-7406.130961
31. Krogel, ¨ I, & Bodmeier¨college, R. (1999a). Development of a multifunctional matrix drug delivery system surrounded by an impermeable cylinder. In Journal of Controlled Release (Vol. 61).
32. Krogel, ¨ I, & Bodmeier¨college, R. (1999b). Development of a multifunctional matrix drug delivery system surrounded by an impermeable cylinder. In Journal of Controlled Release (Vol. 61).
33. Kumari, R., & Kumar Sharma, S. (2021). “FACTORS INFLUENCING THE KINETICS AND MECHANISM OF DRUG RELEASE FROM FLOATING TABLETS.” 11(11).
34. Malleswari, K., Rama, D., Reddy, B., & Reddy, M. N. (n.d.). Pharmaceutical Pellets: A Versatile Carrier for Oral Controlled Delivery of Drugs. In International Journal of Humanities Social Science and Management (IJHSSM) (Vol. 3, Number 1). Retrieved www.ijhssm.org
35. Manna, S., & Kollabathula, J. (2019). Formulation and evaluation of ibuprofen controlled release matrix tablets using its solid dispersion. International Journal of Applied Pharmaceutics, 11(2), 71–76. https://doi.org/10.22159/ijap.2019v11i2.30503
36. Mansoori, S. (2017). AN OVERVIEW OF PELLETIZATION TECHNIQUES USED IN MULTIPARTICULATE DRUG DELIVERY SYSTEM. World Journal of Pharmaceutical Research, 720–741. https://doi.org/10.20959/wjpr20178-9104
37. Mohaniya, P., Modi, D., & Pawar, R. (2024). A REVIEW ON SUSTAINED RELEASE MATRIX TABLET. International Journal of Pharmaceutical Sciences and Medicine, 9(2), 52–58. https://doi.org/10.47760/ijpsm.2024.v09i02.007
38. Mondal, N. (2018). THE ROLE OF MATRIX TABLET IN DRUG DELIVERY SYSTEM Review Article. https://doi.org/10.22159/ijap.2018v10i1.21935
39. Möschwitzer, J. P., & Müller, R. H. (2013). Factors influencing the release kinetics of drug nanocrystal-loaded pellet formulations. Drug Development and Industrial Pharmacy, 39(5), 762–769. https://doi.org/10.3109/03639045.2012.702347
40. Mote, P. B., Rawat, P. K., Singh, S. K., Zadbuke, N. S., Salunke, A. A., & Rajendra, V. B. (2011). FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF ANTI-ASTHMATIC AGENT USING VARIOUS POLYMERS INTRODUCTION. Journal of Drug Delivery & Therapeutics, 2013(3), 88. http://jddtonline.info
41. Nasiri, M. I., Yousuf, R. I., Shoaib, M. H., Fayyaz, M., Qazi, F., & Ahmed, K. (2016). Investigation on release of highly water soluble drug from matrix-coated pellets prepared by extrusion–spheronization technique. Journal of Coatings Technology and Research, 13(2), 333–344. https://doi.org/10.1007/s11998-015-9749-1
42. Nikolakakis, I., & Partheniadis, I. (2017). Self-Emulsifying granules and pellets: Composition and formation mechanisms for instant or controlled release. In Pharmaceutics (Vol. 9, Number 4). MDPI AG. https://doi.org/10.3390/pharmaceutics9040050
43. Pai, R., Kohli, K., & Shrivastava, B. (2012). Compression and evaluation of extended release matrix pellets prepared by the extrusion/spheronization process into disintegrating tablets. In Article Brazilian Journal of Pharmaceutical Sciences (Vol. 48, Number 1).
44. Pauli-Bruns, A., Knop, K., & Lippold, B. C. (2010). Preparation of sustained release matrix pellets by melt agglomeration in the fluidized bed: Influence of formulation variables and modelling of agglomerate growth. European Journal of Pharmaceutics and Biopharmaceutics, 74(3), 503–512. https://doi.org/10.1016/j.ejpb.2009.12.005
45. Penkov, D., Lukova, P., Manev, H., Dimitrova, S., & Kassarova, M. (2023). Polymer Tablet Matrix Systems for the Controlled Release of Dry Betula pendula Leaf Extract. Polymers, 15(17). https://doi.org/10.3390/polym15173558
46. Rajendra Bafna, H., Rajendra Shirsath, N., & Jagtap, V. A. (n.d.-a). A New Path for Drug Delivery by Multiple Unit Pellet System (MUPS).
47. Rajendra Bafna, H., Rajendra Shirsath, N., & Jagtap, V. A. (n.d.-b). A New Path for Drug Delivery by Multiple Unit Pellet System (MUPS).
48. Rao, V. M., Engh, K., & Qiu, Y. (2003). Design of pH-independent controlled release matrix tablets for acidic drugs. In International Journal of Pharmaceutics (Vol. 252).
49. Sarita, J., Hitendra, M., & Patel, R. (n.d.). Indian Journal of Novel Drug Delivery IJNDD An Official Publication of Karnataka Education and Scientific Society Pellets as Drug Delivery System. In Indian Journal of Novel Drug Delivery (Vol. 11, Number 3).
50. Schmidt, C., & Bodmeier, R. (2001). A multiparticulate drug-delivery system based on pellets incorporated into congealable polyethylene glycol carrier materials. In International Journal of Pharmaceutics (Vol. 216). www.elsevier.com/locate/ijpharm
51. Shekhar, S., Kumar, A., Rana, V., Kumar, R., Mittal, C., & Tariyal, K. (2023). Recent Approaches of Matrix Release Tablet in NDDS System. Journal for Research in Applied Sciences and Biotechnology, 2(3), 64–71. https://doi.org/10.55544/jrasb.2.3.9
52. Shukla, R., Shaikh, S., Damor, Y., Jain, H., Sahu, A., & Meshram, D. B. (2020). EAS Journal of Pharmacy and Pharmacology Abbreviated Key Title: EAS J Pharm Pharmacol A Review on Sustained Release Matrix Tablet. https://doi.org/10.36349/easjpp.2020.v02i01.03
53. Siepmann, F., Muschert, S., Flament, M. P., Leterme, P., Gayot, A., & Siepmann, J. (2006). Controlled drug release from Gelucire-based matrix pellets: Experiment and theory. International Journal of Pharmaceutics, 317(2), 136–143. https://doi.org/10.1016/j.ijpharm.2006.03.006
54. Singh, P., Shrivastava, A. K., Kumar, S., & Dwivedi, M. D. (2021). Critical factors in the release of drugs from sustained release hydrophilic matrices. Borneo Journal of Pharmacy, 4(2), 99–109. https://doi.org/10.33084/bjop.v4i2.1854
55. Sirisha, V. R., Vijaya Sri, K., Suresh, K., Reddy, G. K., & Devanna, N. (2013). A REVIEW OF PELLETS AND PELLETIZATION PROCESS-A MULTIPARTICULATE DRUG DELIVERY SYSTEM. International Journal of Pharmaceutical Sciences and Research 2145 IJPSR, 4(6), 2145–2158. https://doi.org/10.13040/IJPSR.0975-8232.4(6).2145-58
56. Sonawane, R. O., & Patil, S. D. (2016). Formulation Aspects and Effect of Critical Factors for Designing Extended Release Pellets: An Updated Review. In Polymer - Plastics Technology and Engineering (Vol. 55, Number 9, pp. 976–989). Taylor and Francis Inc. https://doi.org/10.1080/03602559.2015.1132438
57. Suchita, A. G. (2022). Book 25, Part3. In MATRIX CONTROLLED DRUG RELEASE DRUG DELIVERY IIP Proceedings (Vol. 2).
58. Tangde, S. R., & D Ss saboo, G. Y. (2021). SUSTAINED RELEASE MATRIX TYPE DRUG DELIVERY SYSTEMS; A REVIEW 1*. www.ijcrt.org
59. Tapaswi, *, Dash, R., Verma, P., & Dash, T. R. (2013). Matrix Tablets: An Approach towards Oral Extended Release Drug Delivery. In International Journal of Pharma Research & Review (Vol. 2, Number 2).
60. Tsai, T., San, Y.-P., Ho, H.-O., Wu, J.-S., & Sheu, M.-T. (1998). Film-forming polymer-granulated excipients as the matrix materials for controlled release dosage forms. In Journal of Controlled Release (Vol. 51).
61. Varma, M. V. S., Kaushal, A. M., Garg, A., & Garg, S. (2004a). HEALTHCARE TECHNOLOGY REVIEW Factors Affecting Mechanism and Kinetics of Drug Release from Matrix-Based Oral Controlled Drug Delivery Systems. In Am J Drug Deliv (Vol. 2, Number 1). http://elan.com
62. Varma, M. V. S., Kaushal, A. M., Garg, A., & Garg, S. (2004b). HEALTHCARE TECHNOLOGY REVIEW Factors Affecting Mechanism and Kinetics of Drug Release from Matrix-Based Oral Controlled Drug Delivery Systems. In Am J Drug Deliv (Vol. 2, Number 1). http://elan.com
63. Vergote, G. J., Vervaet, C., Van Driessche, I., Hoste, S., De Smedt, S., Demeester, J., Jain, R. A., Ruddy, S., & Remon, J. P. (2001). An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen. In International Journal of Pharmaceutics (Vol. 219). www.elsevier.com/locate/ijpharm
64. Vo, A. Q., Feng, X., Morott, J. T., Pimparade, M. B., Tiwari, R. V., Zhang, F., & Repka, M. A. (2016a). A novel floating controlled release drug delivery system prepared by hot-melt extrusion. European Journal of Pharmaceutics and Biopharmaceutics, 98, 108–121. https://doi.org/10.1016/j.ejpb.2015.11.015
65. Vo, A. Q., Feng, X., Morott, J. T., Pimparade, M. B., Tiwari, R. V., Zhang, F., & Repka, M. A. (2016b). A novel floating controlled release drug delivery system prepared by hot-melt extrusion. European Journal of Pharmaceutics and Biopharmaceutics, 98, 108–121. https://doi.org/10.1016/j.ejpb.2015.11.015
66. Wairkar, S., & Gaud Shobhaben Pratapbhai, R. (2016). FORMULATION AND IN-VITRO CHARACTERISATION OF SUSTAINED RELEASE MATRIX PELLETS OF NATEGLINIDE. International Journal of Pharmaceutical Sciences and Research, 7(7), 2925. https://doi.org/10.13040/IJPSR.0975-8232.7(7).2925-31
67. Wang, L., Wang, J., Lin, X., & Tang, X. (2010). Preparation and in vitro evaluation of gliclazide sustained-release matrix pellets: Formulation and storage stability. Drug Development and Industrial Pharmacy, 36(7), 814–822. https://doi.org/10.3109/03639040903520967
68. Yadav, N., & Verma, A. (2016). Pharmaceutical pellets: A versatile carrier for oral controlled delivery of drugs. In Indian Journal of Pharmaceutical Education and Research (Vol. 50, Number 3, pp. S146–S160). Association of Pharmaceutical Teachers of India. https://doi.org/10.5530/ijper.50.3.27
69. Zhong, C. (2020). Industrial-Scale Production and Applications of Bacterial Cellulose. In Frontiers in Bioengineering and Biotechnology (Vol. 8). Frontiers Media S.A. https://doi.org/10.3389/fbioe.2020.605374
70. Zhou, F., Vervaet, C., & Remon, J. P. (1997). intemational journal of pharmaceutics Influence of processing on the characteristics of matrix pellets based on microcrystalline waxes and starch derivatives. In International Journal of Pharmaceutics (Vol. 147, Number t997).
71. Zuleger, S., & Lippold, B. C. (2001). Polymer particle erosion controlling drug release. I. Factors influencing drug release and characterization of the release mechanism. In International Journal of Pharmaceutics (Vol. 217). www.elsevier.com/locate/ijpharm